Now I don't think it's necessary raises those questions. It's understandable that KOLs may be hesitant to use the new tech to create embryos without in vivo evidence.
And its good that we got a repeat order from the only KOL using the tech commercially (literally the only news that has prevented me from cutting and running).
What is concerning is how management is not surprised by this. Did the KOLs not mention these reservations 2 years ago when they first got involved?!
At least the trial is being run by Monash ivf, they seem like a well run organisation. I'll be pissed though if we've had a massive share dump, Are told there is no bad news, then Friday end of day we get told some bad news.
And my spidey sense is tingling that may happen...
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-84
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.002(18.2%) |
Mkt cap ! $12.44M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 0.9¢ | $49.61K | 5.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4922245 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 400000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MEM (ASX) Chart |